Genome-scale perturbation signatures from primary human CD4+ T cells improve genetics-based prioritization of immune drug targets
Alexander L. Han, Max Slotnik, David A. Fox, Ryan S. Dhindsa, Johann Eli Gudjonsson, Joanne Michelle Kahlenberg, Joshua D. Welch
The paper introduces IGNITE, a framework that combines genetic data with functional genomics to prioritize immune drug targets, showing improved performance over genetic methods alone.
bioRxiv · Sep 16, 2026 · PreprintBioinformatics